ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Best Shares
2 ASX shares I plan to hold beyond 2030
Coronavirus News
2 ASX health shares leading the coronavirus recovery
⏸️ ASX Shares
5 blue chip ASX 200 shares to buy right now
Share Market News
Top brokers name 3 ASX 200 shares to sell next week
⏸️ ASX Shares
Grow your wealth with these quality ASX healthcare shares
Best Shares
4 ASX market leaders I'm looking to buy right now
Share Market News
Top brokers name 3 ASX 200 shares to sell today
Share Market News
Business confidence down, ASX shares up?
How to invest
3 screening tips to perform when buying ASX shares
Share Market News
Revealed: Which ASX shares will grow during coronavirus?
Healthcare Shares
3 reasons to buy this ASX 200 healthcare share in April
Coronavirus News
These ASX shares are thriving despite the bear market
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
